Archis Pharma LLC
General
Total Cases1
Active Cases--
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 03/01/24 | Summons Issued as to Apicore US LLC on 2/29/2024; Archis Pharma LLC on 2/29/2024; RK Pharma Inc. on 2/29/2024; VGYAAN Pharmaceuticals LLC on 2/29/2024. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued)(mrr) (Entered: 03/01/2024) | |
| 03/01/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo Company, Limited, Corporate Parent Daiichi Sankyo, Inc., Corporate Parent Daiichi Sankyo U.S. Holdings, Inc. for American Regent, Inc. filed by American Regent, Inc. (mrr) (Entered: 03/01/2024) | |
| 02/29/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (mrr) (Entered: 02/29/2024) | |
| 02/29/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: January 25,2024. Date of Expiration of Patent: July 1, 2041.Thirty Month Stay Deadline: 7/25/2026. (mrr) (Entered: 02/29/2024) | |
| 02/29/24 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 02/29/2024) | |
| 02/29/24 | COMPLAINT for PATENT INFRINGEMENT filed against Apicore US LLC, Archis Pharma LLC, RK Pharma Inc., VGYAAN Pharmaceuticals LLC (Filing fee $ 405, receipt number ADEDC-4350893.) - filed by American Regent, Inc. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet)(mrr) (Entered: 02/29/2024) |